Pancreatic Cancer Research

ResearcherLithuanian University of Health SciencesActive in the last 2 years

Giedrius Barauskas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-4321-7280; OpenAlex author ID A5004974743. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 11

  1. Circulating cell-free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non-malignant conditions Co-author DOI 10.1007/s00423-026-04267-0↗
  2. Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathological features of pancreatic cancer. Last author DOI 10.1371/journal.pone.0339964↗
  3. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. Co-author DOI 10.1001/jamaoncol.2024.5917↗
  4. Circulating Cell-Free DNA as a Potential Diagnostic Tool in Pancreatic Cancer: A Comparative Analysis. Co-author DOI 10.1159/000547870↗
  5. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Measuring Perfusion in Pancreatic Ductal Adenocarcinoma and Different Tumor Grade: A Preliminary Singl… Co-author DOI 10.3390/diagnostics13030521↗
  6. Dynamic Perfusion Computed Tomography and Apparent Diffusion Coefficient as Potential Markers for Poorly Differentiated Pancreatic Adenocarcinoma. Last author DOI 10.1159/000511973↗
  7. Dynamic perfusion CT - A promising tool to diagnose pancreatic ductal adenocarcinoma. First author DOI 10.1515/med-2021-0228↗
  8. Preoperative Platelet to Lymphocyte Ratio as a Prognostic Factor for Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. Last author DOI 10.1159/000508444↗
  9. Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.14366↗
  10. CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significant Metabolic Changes That Affect the Qua… Co-author DOI 10.3390/medicina55100649↗
  11. Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study. Co-author DOI 10.1371/journal.pone.0037509↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Povilas Ignatavičius · 8 shared papers, 2019–2026 · strength 1.72
  2. Antanas Gulbinas · 6 shared papers, 2012–2026 · strength 0.99
  3. Žilvinas Dambrauskas · 4 shared papers, 2019–2026 · strength 0.82
  4. Romualdas Riauka · 3 shared papers, 2020–2026 · strength 0.75
  5. Inga Zaborienė · 3 shared papers, 2021–2023 · strength 0.55
  6. Kristina Žvinienė · 3 shared papers, 2021–2023 · strength 0.55
  7. Kęstutis Urbonas · 1 shared paper, 2026 · strength 0.33
  8. Darius Stukas · 1 shared paper, 2026 · strength 0.29
  9. Arenida Bartkevičienė · 1 shared paper, 2026 · strength 0.29
  10. Albertas Daukša · 2 shared papers, 2012–2020 · strength 0.15
  11. Aušra Lukošiūtė - Urbonienė · 1 shared paper, 2020 · strength 0.11
  12. Edita Bieliūnienė · 1 shared paper, 2019 · strength 0.09
  13. Osman El-Maarri · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.